Adverse effects of atypical antipsychotics

Journal of Clinical Psychiatry

Volumn 62, Issue SUPPL. 22, 2001, Pages 7-10

  Wirshing, D A ^a  

^a VA Gt Los Angeles Healthcare Syst ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE;

AGED; BEHAVIOR DISORDER; BODY WEIGHT DISORDER; CONFERENCE PAPER; DEMENTIA; DIABETES MELLITUS; DYSLIPIDEMIA; GLUCOSE METABOLISM; HUMAN; MENTAL DISEASE; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL;

AGED; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; DEMENTIA; DIABETES MELLITUS; GLUCOSE; HUMANS; HYPERLIPIDEMIAS; OBESITY; WEIGHT GAIN;

EID: 0034796535     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (37)

1. Side effect profiles of new antipsychotic agents
2. Association of venous thromboembolism and clozapine
3. Novel antipsychotics and new onset diabetes
4. Current estimates of the economic cost of obesity in the United States
5. Medical hazards of obesity
6. Novel antipsychotics: Comparison of weight gain liabilities
7. 2c serotonin receptors
8. Psychotropic drug induced weight gain: Mechanisms and management
9. Psychotropic drugs promoting weight gain: Health risks and treatment implications
10. Zyprexa
11. Relation of weight gain and weight loss on subsequent diabetes risk in overweight adults
12. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study
13. Clozapine and associated diabetes mellitus
14. A retrospective comparison of lipid, glucose and weight changes at 1 year between olanzapine and risperidone treated inpatients
15. Clozapine might cause new-onset diabetes mellitus
16. Hyperglycemia associated with olanzapine
17. Diabetic ketoacidosis with olanzapine treatment
18. New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment
19. Hyperglycaemia and ketoacidosis on olanzapine
20. Olanzapine-induced ketoacidosis with diabetes mellitus
21. Olanzapine-induced glucose dysregulation
22. Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses
23. New-onset diabetes mellitus associated with the initiation of quetiapine treatment
24. New-onset diabetes mellitus associated with quetiapine
25. Risperidone-associated new onset diabetes
26. Diabetic ketoacidosis associated with risperidone treatment?
27. Differential effects of antipsychotics on type II diabetes: Findings from a large health plan database
28. The risk of developing diabetes in users of atypical antipsychotics
29. Glucose intolerance with atypical antipsychotics
30. Testosterone concentrations in women and men with NIDDM
31. Diabetes mellitus in schizophrenic patients
32. Obesity, weight loss and prognosis in type 2 diabetes
33. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat
34. 1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT and stress-induced increases in plasma adrenaline levels in the rat
35. Hyperglycemic properties of serotonin receptor antagonists